一个简单的酵母显示方法用于抗体面具发现
Nithya M Badarinath1,2, Basudeb Mondal1, Christopher M Yellman1
1School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, United States.
Protein engineering, design & selection : PEDS
|May 17, 2025
概括
研究人员开发了一种酵母显示方法,以发现用于蛋白质治疗的膜. 这种技术可以选防止抗体结合的口罩,直到蛋白质分解性去除,从而提高治疗安全性和疗效.
科学领域:
- 生物技术是生物技术.
- 蛋白质工程是指蛋白质工程.
- 免疫学 免疫学 免疫学
背景情况:
- 蛋白质疗法需要精确控制体内活性,以提高安全性.
- 可以使用掩盖部分来暂时抑制蛋白质对标的治疗结合,直到蛋白质分解裂变发生,通常是由瘤相关的蛋白酶.
- 开发有效的方法来隔离功能掩盖序列对于推进基于蛋白质的疗法至关重要.
研究的目的:
- 建立一种基于酵母显示的方法,用于发现掩盖抗体碎片与抗原标结合的序.
- 为了使在位查恢复抗体结合后的蛋白质溶解面具的去除.
- 为了利用抗原标本身来指导有效口罩的发现.
主要方法:
- 利用酵母显示器将单链可变片段 (scFv) 抗体与其抗原 (PSCA) 的重叠片进行遗传链接.
- 采用流细胞测量来选择表现出抗原结合减少的酵母克隆,识别潜在的线性膜.
- 应用了抗体-抗原复合体 (αHer2) 的共同晶体结构数据,以指导三维表征的组合面具设计.
主要成果:
- 成功识别了两个可以作为PSCA抗原的面具的序列,被证实为线性表位.
- 证明了使用抗原标的可行性,以指导掩盖的发现.
- 通过实验和结构导向方法验证了该方法对线性和三维表征的适用性.
结论:
- 开发的酵母显示方法对于发现抑制抗体-抗原相互作用的膜是有效的.
- 这种方法有助于创建条件活性蛋白疗法,提高安全性和特异性.
- 基于抗原的酵母显示策略显示出对开发具有可调节活性的新型蛋白质疗法的重大前景.
相关概念视频
Antibody Structure
52.5K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
52.5K
Hybridoma Technology
13.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.2K


